Literature DB >> 17533151

Treponema denticola induces interleukin-8 and macrophage chemoattractant protein 1 production in human umbilical vein epithelial cells.

Tomoko Okuda1, Ryuta Kimizuka, Meguru Miyamoto, Tetsuo Kato, Satoru Yamada, Katsuji Okuda, Kazuyuki Ishihara.   

Abstract

Treponema denticola, a major pathogen of periodontitis, has also been detected in the lesions of atherosclerosis. The aim of this study was to investigate induction of chemokine production in human umbilical vein endothelial cells (HUVECs) by T. denticola and determine whether those chemokines were degraded by a protease, dentilisin. T. denticola ATCC35405 or dentilisin-deficient mutant K1 were added to HUVECs and levels of interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) in the culture supernatants were determined by enzyme-linked immunosorbent assay. T. denticola ATCC35405 induced production of IL-8 in a time-dependent manner, with both production of IL-8 and expression of IL-8 mRNA showing higher levels than with exposure to dentilisin-deficient mutant K1. Although exposure to ATCC35405 induced expression of MCP-1 mRNA in the HUVECs, MCP-1 levels were remained similar to that in unstimulated cells. IL-8 and MCP-1 showed partial hydrolysis with exposure to T. denticola ATCC35405, but not with T. denticola K1. These results suggest that T. denticola can evade host defense mechanisms by modulating production of IL-8 and MCP-1, and that this play a role in the development of chronic infections such as periodontitis. The association of T. denticola infection to atherosclerosis was also discussed based on the present study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533151     DOI: 10.1016/j.micinf.2007.03.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

Review 1.  Virulence factors of the oral spirochete Treponema denticola.

Authors:  S G Dashper; C A Seers; K H Tan; E C Reynolds
Journal:  J Dent Res       Date:  2010-10-12       Impact factor: 6.116

2.  Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE(-/-) mice causally links periodontal disease and atherosclerosis.

Authors:  Sasanka S Chukkapalli; Mercedes F Rivera; Irina M Velsko; Ju-Youn Lee; Hao Chen; Donghang Zheng; Indraneel Bhattacharyya; Pandu R Gangula; Alexandra R Lucas; Lakshmyya Kesavalu
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

3.  Dentipain, a Streptococcus pyogenes IdeS protease homolog, is a novel virulence factor of Treponema denticola.

Authors:  Kazuyuki Ishihara; Katarzyna Wawrzonek; Lindesey N Shaw; Satoru Inagaki; Meguru Miyamoto; Jan Potempa
Journal:  Biol Chem       Date:  2010-09       Impact factor: 3.915

4.  Treponema denticola Induces Interleukin-36γ Expression in Human Oral Gingival Keratinocytes via the Parallel Activation of NF-κB and Mitogen-Activated Protein Kinase Pathways.

Authors:  Annie N Hinson; Colin G Hawkes; Christopher S Blake; Zackary R Fitzsimonds; Bin Zhu; Gregory Buck; Richard J Lamont; Daniel P Miller
Journal:  Infect Immun       Date:  2022-08-30       Impact factor: 3.609

5.  Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells.

Authors:  C A Brissette; T-T T Pham; S R Coats; R P Darveau; S A Lukehart
Journal:  Oral Microbiol Immunol       Date:  2008-12

6.  Treponema denticola alters cell vitality and induces HO-1 and Hsp70 expression in porcine aortic endothelial cells.

Authors:  Chiara Bernardini; Paolo Gaibani; Augusta Zannoni; Caterina Vocale; Maria Laura Bacci; Gabriela Piana; Monica Forni; Vittorio Sambri
Journal:  Cell Stress Chaperones       Date:  2009-12-20       Impact factor: 3.667

7.  Behavior of two Tannerella forsythia strains and their cell surface mutants in multispecies oral biofilms.

Authors:  Susanne Bloch; Thomas Thurnheer; Yukitaka Murakami; Georgios N Belibasakis; Christina Schäffer
Journal:  Mol Oral Microbiol       Date:  2017-05-22       Impact factor: 3.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.